Tildrakizumab in the Treatment of Psoriasis: Latest Evidence and Place in Therapy
Therapeutic Advances in Chronic Disease - United States
doi 10.1177/2040622319865658
Full Text
Open PDFAbstract
Available in full text
Categories
Date
January 1, 2019
Authors
Publisher
SAGE Publications